S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
OncLive® On Air
00:00
Tropion‑Breast 05: trials comparing ADC+ICI strategies
Heather McArthur outlines ongoing Tropion‑Breast‑05 comparing Dato‑DXD alone, with ICI, and pembrolizumab+chemotherapy.
Play episode from 18:53
Transcript
